Physician profile
Peter C Wassmer
NPI 1225090657
$4,232.27
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,493 · 2020: $541 · 2021: $1,247 · 2022: $932 · 2023: $19.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $647.93 | 2021-2022 | |
| Abbott Laboratories | $632.98 | 2019-2022 | |
| Biotronik INC. | $629.67 | 2019 | |
| Boston Scientific Corporation | $372.47 | 2021-2022 | |
| Medtronic Vascular, INC. | $294.96 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $274.34 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $235.86 | 2019-2022 | |
| Edwards Lifesciences Corporation | $192.15 | 2019 | |
| Biosense Webster, INC. | $177.03 | 2019-2022 | |
| Amgen INC. | $116.31 | 2019-2022 | |
| Cardiovascular Systems INC. | $103.82 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $79.88 | 2019-2022 | |
| Pfizer INC. | $65.79 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.63 | 2019-2021 | |
| Abiomed | $53.93 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $49.65 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.36 | 2020-2023 | Jardiance |
| Shockwave Medical, INC | $44.65 | 2022 | |
| Sanofi-Aventis U.S. LLC | $43.28 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $40.49 | 2022 | |
| Novo Nordisk INC | $23.20 | 2021 | |
| Cordis US Corp. | $15.44 | 2022 | |
| Preventice Services, LLC | $14.45 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Wassmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.